| Gastric Diffuse Adenocarcinoma studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT03030404completed Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01939275NA · completed 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04253106NA · completed Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06362070NA · unknown Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy · condition mapped ONTOLOGY_EXACT · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06163365unknown Inherited Cancer Early Diagnosis (ICED) Study · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344810Phase 1/Phase 2 · withdrawn C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01212822Phase 2 · completed Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064259Phase 1/Phase 2 · terminated A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061932Phase 2 · completed Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643499Phase 1 · completed Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03950908NA · completed Biopsy Technique for Endoscopic Surveillance of Hereditary Diffuse Gastric Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00633607completed Hereditary Colorectal and Associated Tumor Registry Study · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01612546Phase 2 · completed Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231399Phase 1/Phase 2 · completed Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260701Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084617Phase 2 · completed Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00991952Phase 2 · completed Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01118845Phase 2 · completed Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084604Phase 2 · completed Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103324Phase 2 · completed S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer · condition mapped ALIAS · 21 trials mapped (0 active) | — | — | Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |